BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27645140)

  • 1. Lichen secondary metabolites affect growth of Physcomitrella patens by allelopathy.
    Goga M; Antreich SJ; Bačkor M; Weckwerth W; Lang I
    Protoplasma; 2017 May; 254(3):1307-1315. PubMed ID: 27645140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into physiological responses of mosses Physcomitrella patens and Pohlia drummondii to lichen secondary metabolites.
    Ručová D; Goga M; Sabovljević M; Vilková M; Petruľová V; Bačkor M
    Protoplasma; 2019 Nov; 256(6):1585-1595. PubMed ID: 31243559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients.
    Pompilio A; Pomponio S; Di Vincenzo V; Crocetta V; Nicoletti M; Piovano M; Garbarino JA; Di Bonaventura G
    Future Microbiol; 2013 Feb; 8(2):281-92. PubMed ID: 23374132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Larvicidal activity of some secondary lichen metabolites against the mosquito Culiseta longiareolata Macquart (Diptera: Culicidae).
    Cetin H; Tufan-Cetin O; Turk AO; Tay T; Candan M; Yanikoglu A; Sumbul H
    Nat Prod Res; 2012; 26(4):350-5. PubMed ID: 21452097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical composition of three Parmelia lichens and antioxidant, antimicrobial and cytotoxic activities of some their major metabolites.
    Manojlović N; Ranković B; Kosanić M; Vasiljević P; Stanojković T
    Phytomedicine; 2012 Oct; 19(13):1166-72. PubMed ID: 22921748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of lichen metabolites evernic and usnic acids against redox impairment-mediated cytotoxicity in central nervous system-like cells.
    Fernández-Moriano C; Divakar PK; Crespo A; Gómez-Serranillos MP
    Food Chem Toxicol; 2017 Jul; 105():262-277. PubMed ID: 28450128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lichen-derived compounds show potential for central nervous system therapeutics.
    Reddy RG; Veeraval L; Maitra S; Chollet-Krugler M; Tomasi S; Dévéhat FL; Boustie J; Chakravarty S
    Phytomedicine; 2016 Nov; 23(12):1527-1534. PubMed ID: 27765373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antimicrobial activity of extracts of the lichen Cladonia foliacea and its (-)-usnic acid, atranorin, and fumarprotocetraric acid constituents.
    Yilmaz M; Türk AO; Tay T; Kivanç M
    Z Naturforsch C J Biosci; 2004; 59(3-4):249-54. PubMed ID: 15241936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable responses of different human cancer cells to the lichen compounds parietin, atranorin, usnic acid and gyrophoric acid.
    Bačkorová M; Bačkor M; Mikeš J; Jendželovský R; Fedoročko P
    Toxicol In Vitro; 2011 Feb; 25(1):37-44. PubMed ID: 20837130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimycobacterial activity of lichen metabolites in vitro.
    Ingólfsdóttir K; Chung GA; Skúlason VG; Gissurarson SR; Vilhelmsdóttir M
    Eur J Pharm Sci; 1998 Apr; 6(2):141-4. PubMed ID: 9795033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atranorin - An Interesting Lichen Secondary Metabolite.
    Studzinska-Sroka E; Galanty A; Bylka W
    Mini Rev Med Chem; 2017; 17(17):1633-1645. PubMed ID: 28443519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxic activity and antioxidant capacity of purified lichen metabolites: an in vitro study.
    Brisdelli F; Perilli M; Sellitri D; Piovano M; Garbarino JA; Nicoletti M; Bozzi A; Amicosante G; Celenza G
    Phytother Res; 2013 Mar; 27(3):431-7. PubMed ID: 22628260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of Anti-Cancer and Related Properties of Lichen-Extracts and Metabolites.
    Tripathi AH; Negi N; Gahtori R; Kumari A; Joshi P; Tewari LM; Joshi Y; Bajpai R; Upreti DK; Upadhyay SK
    Anticancer Agents Med Chem; 2022; 22(1):115-142. PubMed ID: 34225637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lichen secondary metabolites as DNA-interacting agents.
    Plsíkova J; Stepankova J; Kasparkova J; Brabec V; Backor M; Kozurkova M
    Toxicol In Vitro; 2014 Mar; 28(2):182-6. PubMed ID: 24269500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiangiogenic properties of lichen secondary metabolites.
    Ulus G
    Phytother Res; 2021 Jun; 35(6):3046-3058. PubMed ID: 33587324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecological implication of variation in the secondary metabolites in Parmelioid lichens with respect to altitude.
    Shukla V; Patel DK; Bajpai R; Semwal M; Upreti DK
    Environ Sci Pollut Res Int; 2016 Jan; 23(2):1391-7. PubMed ID: 26370809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubilization of poorly soluble lichen metabolites for biological testing on cell lines.
    Kristmundsdóttir T; Jónsdóttir E; Ogmundsdóttir HM; Ingólfsdóttir K
    Eur J Pharm Sci; 2005 Apr; 24(5):539-43. PubMed ID: 15784343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Cancer Activity of Lobaric Acid and Lobarstin Extracted from the Antarctic Lichen Stereocaulon alpnum.
    Hong JM; Suh SS; Kim TK; Kim JE; Han SJ; Youn UJ; Yim JH; Kim IC
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29538328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atranorin and lecanoric acid antagonize TCDD-induced xenobiotic response element-driven activity, but not xenobiotic response element-independent activity.
    Nakashima K; Tanabe H; Fujii-Kuriyama Y; Hayashi H; Inoue M
    J Nat Med; 2016 Jul; 70(3):476-82. PubMed ID: 26979434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lichen metabolites. 2. Antiproliferative and cytotoxic activity of gyrophoric, usnic, and diffractaic acid on human keratinocyte growth.
    Kumar KC; Müller K
    J Nat Prod; 1999 Jun; 62(6):821-3. PubMed ID: 10395495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.